SCHEMBL17015609

SCHEMBL17015609

O=P(c1ccccc1)(c1ccccc1)c1ccc(-n2c3ccccc3c3c4c(ccc32)ccn4-c2ccccc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.39
▸ ATM Q13315 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ DHODH Q02127 1/20 0.32
▸ PGR P06401 1/20 0.32
▸ JAK2 O60674 1/20 0.31
▸ JAK3 P52333 1/20 0.31
▸ HKDC1 Q2TB90 1/20 0.31
▸ BIRC5 O15392 1/20 0.31
▸ HDAC4 P56524 2/20 0.30
▸ HDAC3 O15379 1/20 0.30
▸ HDAC1 Q13547 1/20 0.30
▸ HDAC7 Q8WUI4 1/20 0.30
▸ HDAC2 Q92769 1/20 0.30
▸ HDAC10 Q969S8 1/20 0.30
▸ HDAC11 Q96DB2 1/20 0.30
▸ HDAC8 Q9BY41 1/20 0.30
▸ HDAC6 Q9UBN7 1/20 0.30
▸ HDAC9 Q9UKV0 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17015611 0.91 NPSR1 (0.37) KDM4EATML3MBTL1NPSR1DHODH
SCHEMBL15632394 0.88 L3MBTL1 (0.45) KDM4EATML3MBTL1NPSR1PGR
SCHEMBL16357565 0.88 KDM4E (0.51) KDM4EATML3MBTL1PGRJAK2
SCHEMBL16357447 0.88 KDM4E (0.50) KDM4EATML3MBTL1PGRJAK2
SCHEMBL20426227 0.87 L3MBTL1 (0.44) KDM4EATML3MBTL1PGRJAK2
SCHEMBL15632146 0.87 L3MBTL1 (0.47) KDM4EATML3MBTL1PGRJAK2
SCHEMBL16357467 0.87 L3MBTL1 (0.44) KDM4EATML3MBTL1PGRJAK2
SCHEMBL17015533 0.85 KDM4E (0.42) KDM4EATML3MBTL1NPSR1DHODH
SCHEMBL17015372 0.85 KDM4E (0.40) KDM4EATML3MBTL1NPSR1DHODH
SCHEMBL17016247 0.85 KDM4E (0.40) KDM4EATML3MBTL1NPSR1DHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9837618-B2 Compound and organic electroluminescence device including thesame DOOSAN CORPORATION (KR) 2017-12-05 — — US disclosed
US-9837618-B2 Compound and organic electroluminescence device including thesame DOOSAN CORPORATION (KR) 2017-12-05 — — US disclosed
US-20150236272-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THESAME DOOSAN CORPORATION (KR) 2015-08-20 — — US disclosed
US-20150236272-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THESAME DOOSAN CORPORATION (KR) 2015-08-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150236272-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THESAME INMT, IDO1, IDO2 KDM4E 1286/4885ATM 3623/4885L3MBTL1 533/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback